Hannah J Lee1, Yvonne Roed2, Sara Venkataraman3, Mitchell Carroll4, Geoffrey S Ibbott5. 1. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, USA. Electronic address: HJLee1@mdanderson.org. 2. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Physics, University of Houston, USA. 3. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA. 4. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, USA. 5. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: GIbbott@mdanderson.org.
Abstract
BACKGROUND AND PURPOSE: The strong magnetic field of integrated magnetic resonance imaging (MRI) and radiation treatment systems influences secondary electrons resulting in changes in dose deposition in three dimensions. To fill the need for volumetric dose quality assurance, we investigated the effects of strong magnetic fields on 3D dosimeters for MR-image-guided radiation therapy (MR-IGRT) applications. MATERIAL AND METHODS: There are currently three main categories of 3D dosimeters, and the following were used in this study: radiochromic plastic (PRESAGE®), radiochromic gel (FOX), and polymer gel (BANG™). For the purposes of batch consistency, an electromagnet was used for same-day irradiations with and without a strong magnetic field (B0, 1.5T for PRESAGE® and FOX and 1.0T for BANG™). RESULTS: For PRESAGE®, the percent difference in optical signal with and without B0 was 1.5% at the spectral peak of 632nm. For FOX, the optical signal percent difference was 1.6% at 440nm and 0.5% at 585nm. For BANG™, the percent difference in R2 MR signal was 0.7%. CONCLUSIONS: The percent differences in responses with and without strong magnetic fields were minimal for all three 3D dosimeter systems. These 3D dosimeters therefore can be applied to MR-IGRT without requiring a correction factor.
BACKGROUND AND PURPOSE: The strong magnetic field of integrated magnetic resonance imaging (MRI) and radiation treatment systems influences secondary electrons resulting in changes in dose deposition in three dimensions. To fill the need for volumetric dose quality assurance, we investigated the effects of strong magnetic fields on 3D dosimeters for MR-image-guided radiation therapy (MR-IGRT) applications. MATERIAL AND METHODS: There are currently three main categories of 3D dosimeters, and the following were used in this study: radiochromic plastic (PRESAGE®), radiochromic gel (FOX), and polymer gel (BANG™). For the purposes of batch consistency, an electromagnet was used for same-day irradiations with and without a strong magnetic field (B0, 1.5T for PRESAGE® and FOX and 1.0T for BANG™). RESULTS: For PRESAGE®, the percent difference in optical signal with and without B0 was 1.5% at the spectral peak of 632nm. For FOX, the optical signal percent difference was 1.6% at 440nm and 0.5% at 585nm. For BANG™, the percent difference in R2 MR signal was 0.7%. CONCLUSIONS: The percent differences in responses with and without strong magnetic fields were minimal for all three 3D dosimeter systems. These 3D dosimeters therefore can be applied to MR-IGRT without requiring a correction factor.
Authors: Jacqueline M Andreozzi; Petr Brůža; Jochen Cammin; Brian W Pogue; David J Gladstone; Olga Green Journal: Med Phys Date: 2019-12-25 Impact factor: 4.071
Authors: Morten B Jensen; Peter Balling; Simon J Doran; Jørgen B B Petersen; Isak H Wahlstedt; Ludvig P Muren Journal: Phys Imaging Radiat Oncol Date: 2020-10-19
Authors: Filipa Costa; Simon J Doran; Ian M Hanson; Simeon Nill; Ilias Billas; David Shipley; Simon Duane; John Adamovics; Uwe Oelfke Journal: Phys Med Biol Date: 2018-02-26 Impact factor: 3.609
Authors: Christopher Kurz; Giulia Buizza; Guillaume Landry; Florian Kamp; Moritz Rabe; Chiara Paganelli; Guido Baroni; Michael Reiner; Paul J Keall; Cornelis A T van den Berg; Marco Riboldi Journal: Radiat Oncol Date: 2020-05-05 Impact factor: 3.481